Abstract | PURPOSE: MATERIALS AND METHODS: A total of 42 boys 11 to 100 months old (median 33.5) with 63 undescended testes were prospectively assigned to 2 groups during a 6-month period. Patients were randomized to receive either orchiopexy alone (21 patients) or with neoadjuvant GNRH therapy (21) as a nasal spray for 4 weeks at 1.2 mg per day. In both groups testicular biopsies were performed at the time of orchiopexy and histopathological fertility index was determined. RESULTS: Mean fertility index in the group treated with GNRH before surgery was significantly higher (1.05, SD +/- 0.71) compared to the group without hormonal stimulation (0.52, SD +/- 0.39, p <0.05). The subgroup of neoadjuvant stimulated boys younger than 24 months achieved the best results compared to the age matched boys without hormonal treatment. CONCLUSIONS: Neoadjuvant GNRH treatment improves fertility index in prepubertal cryptorchidism. Consequently, preoperative hormone therapy should improve fertility in adulthood. Additionally, the nasal application is well tolerated, safe and already recommended in an adjuvant setting after orchiopexy. Maximum salvage of active germinal tissue is achieved by treating cryptorchidism before the end of the first year of life.
|
Authors | Christian Schwentner, Josef Oswald, Alfons Kreczy, Andreas Lunacek, Georg Bartsch, Martina Deibl, Christian Radmayr |
Journal | The Journal of urology
(J Urol)
Vol. 173
Issue 3
Pg. 974-7
(Mar 2005)
ISSN: 0022-5347 [Print] United States |
PMID | 15711353
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Gonadotropin-Releasing Hormone
|
Topics |
- Chemotherapy, Adjuvant
- Child
- Child, Preschool
- Cryptorchidism
(complications, drug therapy, surgery)
- Gonadotropin-Releasing Hormone
(therapeutic use)
- Humans
- Infant
- Infertility, Male
(etiology, prevention & control)
- Male
- Preoperative Care
- Prospective Studies
- Spermatogonia
|